retatrutide mechanism triple agonist gip glp-1 glucagon receptor Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data The Science Behind Retatrutide: A

Inflammatory markers decrease, potentially reducing vascular inflammation

It has been dermatologically tested

Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive adults with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial

While these medications suppress appetite effectively, they can inadvertently lead to insufficient protein consumption, increasing the risk of muscle loss alongside fat reduction

Melanie Peterson for her assistance in the preparation of this manuscript